horizon

human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; mole Read More

Classification Information

Class [1]
Chemical Products

Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes; biological and chemical reagents, including, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use.

Class [5]
Pharmaceutical Products

Protein cell lysates, genomic DNA preparations and FFPE engineered tumor mimics for diagnostic use.

Class [42]
Computer & Software Services & Scientific Services

Custom cell-line engineering services; gene-editing services; DNA modeling services; gene engineering services; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; biology and chemistry services; pharmaceutical research services; drug discovery services; research and development services for lead identification and validation; research and development services for target identification and validation; identification of patient-relevant drug targets; optimisation of drug candidates for clinical development; diagnostic services; medicinal and synthetic chemistry services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines, chemicals and compounds; creating libraries or collections of normal and mutated genes; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications.

Mark Details

Serial Number

UK00911894292

Mark Type

Figurative

Kind of mark

Individual